Clarendon
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Sonas Pharma secures pre-seed funding led by SFC Capital to develop therapeutics for obesity and epilepsy
Sonas Pharma develops small-molecule therapeutics targeting the endocannabinoid system. Its programmes focus on treating obesity and epilepsy by designing drugs intended to act on specific biological mechanisms.
TeamFeePay announces £9m in funding led by YFM Equity Partners for grassroots sports club management software
TeamFeePay develops management software for grassroots sports clubs, helping coaches and volunteers handle payments, scheduling and administration so they can focus more time on sport and community.
Neurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technology
Neurovalens designs non-invasive neurostimulation devices that treat conditions such as insomnia and anxiety, using wearable technology cleared for clinical use.
Fluid Focus secures £640k funding from Invest NI via Clarendon to reward healthier screentime habits
Fluid Focus operates an app that rewards healthier screentime and productivity habits, helping users reduce time on distracting apps while earning incentives linked to wellbeing and focus.
Cumulus Neuroscience secures £3m in funding led by Whiterock to scale AI-powered neurology trials
Cumulus Neuroscience supports clinical trials with AI powered brain data collection tools, combining wearable EEG hardware and digital assessments to improve neurological research and drug development.
Inclutech lands £400k in funding from Innovation Ulster and Clarendon to develop safety platform for high-risk victims
Inclutech builds inclusive public safety technology, including accredited emergency service apps, to help vulnerable users communicate in crises and support authorities with accessible, real-time incident information.
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy
StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.
More venture news
- 2 Mar 2026
Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable
Pre-seedLife Sciences - 25 Feb 2026
Tattvam AI raises £1.3m in a pre-seed round led by Seedcamp to automate semiconductor chip design
Pre-seedDeep Tech - 26 Feb 2026
TetraTetra secures a £450k pre-seed round from angels for surgical scheduling software for hospitals
Pre-seedHealth
